Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
15%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
CANC
56
HOLDINGS
27%
ALSO IN SBIO
SBIO
86
HOLDINGS
17%
ALSO IN CANC
SECTOR DRIFT (CANC minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CG ONCOLOGY, INC. | 2.9% | 3.5% | 2.9% |
|
IDEAYA BIOSCIENCES, INC. | 2.6% | 1.7% | 1.7% |
|
RELAY THERAPEUTICS, INC. | 1.7% | 2.1% | 1.7% |
|
IMMUNOME, INC. | 3.0% | 1.6% | 1.6% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 1.9% | 1.4% | 1.4% |
CANC Overweight Relative to SBIO
|
REVOLUTION MEDICINES, INC. | 6.0% |
|
ELI LILLY & CO | 5.4% |
|
COGENT BIOSCIENCES INC | 4.8% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.4% |
|
NOVARTIS AG | 3.8% |
|
MERCK & CO. INC. | 3.6% |
|
BRISTOL-MYERS SQUIBB CO | 3.5% |
|
ABBVIE INC | 3.3% |
|
BEIGENE LTD. SPONSORED ADR | 3.2% |
|
HALOZYME THERAPEUTICS INC | 3.1% |
CANC Underweight Relative to SBIO
|
CRINETICS PHARMACEUTICALS INC | -4.4% |
|
APOGEE THERAPEUTICS, INC. | -4.1% |
|
ORUKA THERAPEUTICS INC | -3.2% |
|
TRAVERE THERAPEUTICS, INC. | -3.0% |
|
DIANTHUS THERAPEUTICS INC | -3.0% |
|
ACADIA PHARMACEUTICALS INC | -2.5% |
|
DEFINIUM THERAPEUTICS INC | -2.4% |
|
EDGEWISE THERAPEUTICS, INC. | -2.4% |
|
DYNE THERAPEUTICS INC | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |